* Ultralife Corp ULBI.OQ reported quarterly adjusted
earnings of
10 cents per share for the quarter ended in September. The
lone analyst forecast for the quarter was for earnings of 10
cents per share.
* Revenue rose 18.8% to $39.49 million from a year ago;
analysts
expected $39.50 million.
* Ultralife Corp's reported EPS for the quarter was 8
cents.
* The mean earnings estimate of analysts had risen by
about 11.1%
in the last three months.
* In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.
* Ultralife Corp shares had fallen by 5.7% this quarter and
gained 138.3% so far this year.
* The company reported quarterly net income of $1.33
million.
* Wall Street's median 12-month price target for Ultralife
Corp is
$12.00
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 1 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell."
This summary was machine generated from LSEG Refinitiv data
October 26 at 02:48 p.m. UTC. All figures in US dollars unless
otherwise stated. QUARTER ENDING ESTIMATE ACTUAL BEAT, MET,
MISSED
Sep. 30 2023 0.10 0.10 Met
Jun. 30 2023 0.04 0.29 Beat
Mar. 31 2023 -0.10 -0.01 Beat